|
|
|
Insider
Information: |
Altshuler David |
Relationship: |
EVP, Global Research a... |
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
25,813 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$11,292,929 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
25,813 |
|
|
Total
Value |
$11,292,929 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Vertex Pharmaceuticals Inc |
VRTX |
EVP, Global Research a... |
2024-02-26 |
25,813 |
2014-07-31 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
156 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2014-07-31 |
4 |
AS |
$88.76 |
$375,238 |
D/D |
(4,200) |
0 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2014-09-05 |
4 |
AS |
$94.75 |
$236,875 |
D/D |
(2,500) |
0 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2014-09-19 |
4 |
AS |
$99.75 |
$511,250 |
D/D |
(5,000) |
0 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2014-09-24 |
4 |
AS |
$109.75 |
$274,375 |
D/D |
(2,500) |
0 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2014-09-29 |
4 |
AS |
$114.75 |
$286,875 |
D/D |
(2,500) |
0 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2014-10-01 |
4 |
AS |
$106.56 |
$1,141,531 |
D/D |
(10,595) |
0 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2014-10-06 |
4 |
AS |
$109.75 |
$154,199 |
D/D |
(1,405) |
0 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2014-10-28 |
4 |
AS |
$114.75 |
$229,500 |
D/D |
(2,000) |
0 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2014-11-28 |
4 |
AS |
$119.75 |
$419,125 |
D/D |
(3,500) |
0 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2004-07-31 |
4 |
AS |
$90.86 |
$72,688 |
D/D |
(800) |
100 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2014-10-06 |
4 |
OE |
$63.14 |
$88,712 |
D/D |
1,405 |
1,405 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2014-10-28 |
4 |
OE |
$63.14 |
$126,280 |
D/D |
2,000 |
2,000 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2014-09-05 |
4 |
OE |
$59.55 |
$148,875 |
D/D |
2,500 |
2,500 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2014-09-24 |
4 |
OE |
$59.55 |
$148,875 |
D/D |
2,500 |
2,500 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2014-09-29 |
4 |
OE |
$59.55 |
$148,875 |
D/D |
2,500 |
2,500 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2014-11-28 |
4 |
OE |
$59.55 |
$212,015 |
D/D |
3,500 |
3,500 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2014-07-31 |
4 |
OE |
$59.55 |
$297,750 |
D/D |
5,000 |
5,000 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2014-09-19 |
4 |
OE |
$59.55 |
$297,750 |
D/D |
5,000 |
5,000 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
Director |
|
2014-10-01 |
4 |
OE |
$63.14 |
$668,968 |
D/D |
10,595 |
10,595 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Global Research and CSO |
|
2024-02-26 |
4 |
AS |
$425.70 |
$1,804,542 |
D/D |
(4,239) |
25,813 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Global Research and CSO |
|
2020-02-25 |
4 |
AS |
$229.72 |
$706,776 |
D/D |
(3,028) |
28,902 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Global Research and CSO |
|
2020-05-04 |
4 |
AS |
$259.18 |
$607,803 |
D/D |
(2,330) |
28,902 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Global Research and CSO |
|
2020-05-06 |
4 |
AS |
$270.20 |
$333,195 |
D/D |
(1,222) |
28,902 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Global Research and CSO |
|
2020-05-12 |
4 |
AS |
$287.33 |
$374,678 |
D/D |
(1,304) |
28,902 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Global Research and CSO |
|
2020-05-15 |
4 |
AS |
$274.98 |
$23,318 |
D/D |
(82) |
28,902 |
0 |
% |
|
156 Records found
|
|
Page 1 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|